Companies / Kiniksa Pharmaceuticals International, plc

Kiniksa Pharmaceuticals International, plc

Nasdaq: KNSACIK 1730430LONDON

Financials · FY2025

Revenue$677.56M
Net income$59.01M
Total debt—
Cash$189.95M
Diluted EPS$0.75
Shares outstanding156.0M

Ownership

156.0M shares outstanding · as of Jul 24, 2026
3.1%10%+ / strategic
Ownership
50.0%Common Stock
Share classes
Common Stock50.00%
Class A30.95%
Class B10.29%
Class A8.19%
Class B0.57%
10%+ / strategic3.11%4,854,354
Institutions28.45%44,394,314
Public float68.44%106,799,358

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 12

View all →
Insider% of sharesShares
667, L.P.Director
——
Baker Bros. Advisors (GP) LLCDirector
——
Baker Bros. Advisors LPDirector
——
Baker Brothers Life Sciences LPDirector
——
Baker FelixDirector
——
Baker JulianDirector
——
Cole G BradleyDirector
——
Levy Richard SDirector
——
Paolini John F.CHIEF MEDICAL OFFICER
——
Popovits Kimberly JDirector
——

Institutional holders 232

View all →
HolderValue% of shares
BlackRock, Inc.$175.20M1.76%
Rubric Capital Management LP$137.31M2.13%
Baker Bros. Advisors LP$136.08M1.81%
Vanguard Group Inc$128.41M1.99%
Tang Capital Management, LLC$108.81M1.45%
Fmr LLC$67.77M1.05%
Morgan Stanley$56.10M0.87%
Fairmount Funds Management LLC$54.44M0.85%
D. E. Shaw & Co., Inc.$46.19M0.61%
State Street Corporation$45.03M0.45%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Mar 2, 2026Paolini John F.
Executive
SellClass A Ordinary Share$997.4K-22K
-24.90%
67,038
0.04% of shares
medium
Mar 9, 2026Ragosa Mark
Executive
SellClass A Ordinary Share$866.6K-19K
-60.79%
12,086
<0.01% of shares
medium
Mar 9, 2026Ragosa Mark
Executive
SellClass A Ordinary Share$819.6K-18K
-36.84%
30,827
0.02% of shares
medium
Apr 28, 2026Quart Barry D
Director
SellClass A Ordinary Share$656.3K-13K
-51.08%
12,546
<0.01% of shares
medium
Feb 3, 2026Quart Barry D
Director
SellClass A Ordinary Share$567.1K-13K
-49.96%
12,546
<0.01% of shares
medium
Mar 2, 2026Paolini John F.
Executive
SellClass A Ordinary Share$533.2K-12K
-11.91%
89,261
0.06% of shares
medium
Jan 8, 2026Ragosa Mark
Executive
SellClass A Ordinary Share$502.7K-12K
-38.60%
19,086
0.01% of shares
medium
Mar 2, 2026Paolini John F.
Executive
ExerciseClass A Ordinary Share$414.4K+40K
+65.23%
101,324
0.06% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vanguard Group IncPassive13G/A—0—
Rubric Capital Management LPPassive13G/A———
Fmr LLCPassive13G—4,854,354—

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
KNSA——G52694109—